(Q44351064)

2 December 2017

Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis (English)

1 reference

2 December 2017

Gülay Demircin

1

1 reference

2 December 2017

Ayse Oner

2

1 reference

2 December 2017

Ozlem Erdoğan

3

1 reference

2 December 2017

Ali Delibaş

4

1 reference

2 December 2017

Sahika Baysun

5

1 reference

2 December 2017

Mehmet Bülbül

6

1 reference

2 December 2017

Kenan Bek

7

1 reference

2 December 2017

Ayşegül Oksal

8

1 reference

2 December 2017

1 January 2008

1 reference

2 December 2017

1 reference

2 December 2017

30

1 reference

2 December 2017

6

1 reference

2 December 2017

603-609

1 reference

Lupus nephritis: lessons from the path lab.

2 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Treatment of lupus nephritis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Lupus nephritis in childhood: a review of 53 patients followed at a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Clinicopathological study of the WHO classification in childhood lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Intravenous cyclophosphamide--resistant systemic lupus erythematosus in Arizona

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Retrospective study of plasma exchange in children with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Outcome of silent lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Newer drugs for the treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

Relapse of lupus nephritis more than 10 years after complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08860220802132171

10.1080/08860220802132171

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference